Scar treatment products provide scar management solutions for different types of scars such as acne scars, surgical scars, hypertrophic and keloid scars. Acne scar treatment creams help reduce the appearance of acne lesions and scarring. These creams contain ingredients like glycolic acid, retinol, vitamin C and niacinamide that help exfoliate skin and boost collagen production. The increasing prevalence of skin conditions like acne and rise in number of surgical procedures have fueled the demand for scar treatment products. The global Scar Treatment Market is estimated to be valued at US$ 12,020.05 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the scar treatment market is increasing preference for scar mitigating treatment options such as laser scar removal, injectable fillers and topical scar reduction creams. Laser therapy uses difference wavelengths of light to treat scars. CO2 and fractional lasers are commonly used for scar removal. The treatment breaks up scar tissue and stimulates new collagen production. Similarly, injectable hyaluronic acid and calcium hydroxyapatite fillers are widely adopted to reduce the appearance of atrophic scars. Rising consumer awareness about minimally invasive scar management solutions through online health portals and social media marketing campaigns by leading companies are some factors fueling the adoption of laser therapy and injectable fillers for scar removal.
Segment Analysis
The global scar treatment market is dominated by the hypertrophic and keloid segment. Hypertrophic and keloid scars are characterized by excessive growth of collagen bundles leading to raised, irregularly shaped scars. Treatment of hypertrophic and keloid scars remains a major clinical challenge accounting for more significant proportion of treatments and products available in the market. They are more common and challenging to treat compared to other scar types.
Key Takeaways
The global scar treatment market is expected to witness high growth due to the increasing prevalence of surgeries and accidental injuries.
Regional analysis: The Asia Pacific region is expected to witness the fastest growth in the global scar treatment market during the forecast period. Growing medical tourism industry and rise in disposable incomes are increasing the demand for scar treatment procedures in the region. Countries such as India, Thailand, South Korea, and China are emerging as popular medical tourism destinations providing cost-effective scar treatment options.
Key players operating in the scar treatment market are Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma Pharmaceuticals Inc., Hologic Inc., Johnson & Johnson Services Inc., Quantum Health, CCA Industries Inc., AVITA Medical, Revitol Corp, Scarguard labs, Smith+Nephew, Lumenis Be Ltd, Merz Therapeutics, Cynosure, HRA Pharma, GC Aesthetics, Sientra Inc., SkinCeuticals, Cimeosil.com, Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd. Bausch Health Companies Inc. offers scar treatment products under the brands Scar Zone, AquaGold, and Dermalive.
No comments:
Post a Comment